期刊
JOURNAL OF INFECTION AND CHEMOTHERAPY
卷 22, 期 3, 页码 174-179出版社
ELSEVIER
DOI: 10.1016/j.jiac.2015.12.009
关键词
Rifampicin; Isoniazid; Mycobacterium tuberculosis; Resistance; Myanmar
资金
- J-GRID
- the Japan Initiative for Global Research Network on Infectious Diseases from the Ministry of Education, Culture, Sports, Science, and Technology, Japan (MEXT) [10010015]
- JSPS KAKENHI Grant [24406021, 24580443]
- MEXT
- Global COE Program, the Establishment of International Collaboration Centers for Zoonosis Control, Hokkaido University from MEXT
- U.S.-Japan Cooperative Medical Science Programs
- Grants-in-Aid for Scientific Research [24406021, 24580443] Funding Source: KAKEN
The number of multi-drug-resistant tuberculosis (MDR-TB) cases is rising worldwide. As a countermeasure against this situation, the implementation of rapid molecular tests to identify MDR-TB would be effective. To develop such tests, information on the frequency and distribution of mutations associating with phenotypic drug resistance in Mycobacterium tuberculosis is required in each country. During 2010, the common mutations in the rpoB, katG and inhA of 178 phenotypically MDR M. tuberculosis isolates collected by the National Tuberculosis Control Program (NTP) in Myanmar were investigated by DNA sequencing. Mutations affecting the 81-bp rifampicin (RIF) resistance-determining region (RRDR) of the rpoB were identified in 127 of 178 isolates (71.3%). Two of the most frequently affected codons were 531 and 526, with percentages of 48.3% and 14.0% respectively. For isoniazid (INH) resistance, 114 of 178 MDR-TB isolates (64.0%) had mutations in the katG in which a mutation-conferring amino acid substitution at codon 315 from Ser to Thr was the most common. Mutations in the inhA regulatory region were also detected in 20 (11.2%) isolates, with the majority at position -15. Distinct mutation rate and pattern from surrounding countries might suggest that MDR-TB has developed and spread domestically in Myanmar. (C) 2015, Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据